Lumida
/VNDA
⌘K
Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals Inc

VNDA
$5.44USD-0.18%-0.01 today

MARKET CAP

327.1M

P/E (TTM)

FWD P/E

DAY RANGE

$5 – $5

52W RANGE

$4
$10

AI Summary

Stalk
TrimMedium

VNDA remains in a sustained Stage 4 decline with a clear sequence of lower highs and lower lows and a primary Support Failure pattern. Volume expansion on down moves and declining EMAs confirm medium-term bearish permission, but extreme oversold readings and extended price below sloping EMAs argue against immediate selling. Under a Speculative mandate, we defer entry until a reaction rally into the falling 9/21 EMAs offers a disciplined shorting opportunity in the resistance zone.

  • Q1 revenue $51.7M up 3% YoY, led by FNAP +26%
  • 2026 revenue guidance raised to $240–$290M
  • Net loss $48.6M in Q1 vs. $29.5M prior year, driven by SG&A rise
Full analysis →
Insider Trades27 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Mar 2, 2026SellVNDAJoakim WijkstromSVP, Chief Marketing Officer30,800$8.27$327.1M-45.27%+31.40%$254.6K-8.46%Trim
Mar 2, 2026SellVNDAGunther BirznieksSVP, Business Development42,431$8.27$327.1M-45.27%+31.40%$350.7K-7.91%Trim
Mar 2, 2026SellVNDATimothy WilliamsSVP & General Counsel42,434$8.27$327.1M-45.27%+31.40%$350.8K-10.11%Trim
Mar 2, 2026SellVNDAKevin Patrick MoranSVP, CFO & Treasurer42,442$8.27$327.1M-45.27%+31.40%$350.8K-9.35%Trim
Mar 2, 2026SellVNDAMihael Hristos PolymeropoulosPresident and CEO156,235$8.17$327.1M-45.27%+31.40%$1.3M-5.46%Trim
Aug 7, 2025BuyVNDAMihael Hristos PolymeropoulosPresident and CEO10,000$4.15$327.1M-45.27%+31.40%$41.5K+0.43%Trim
May 21, 2025BuyVNDAMihael Hristos PolymeropoulosPresident and CEO10,000$4.40$327.1M-45.27%+31.40%$44.0K+0.22%Trim
May 16, 2025BuyVNDAMihael Hristos PolymeropoulosPresident and CEO20,000$4.22$327.1M-45.27%+31.40%$84.5K+0.87%Trim
Mar 6, 2025BuyVNDAMihael Hristos PolymeropoulosPresident and CEO10,000$5.01$327.1M-45.27%+31.40%$50.1K+0.22%Trim
Mar 5, 2025BuyVNDAMihael Hristos PolymeropoulosPresident and CEO10,000$5.02$327.1M-45.27%+31.40%$50.2K+0.22%Trim
Mar 1, 2025SellVNDAJoakim WijkstromSVP, Chief Marketing Officer15,520$4.76$327.1M-45.27%+31.40%$73.9K-6.09%Trim
Mar 1, 2025SellVNDATimothy WilliamsSVP & General Counsel26,941$4.76$327.1M-45.27%+31.40%$128.2K-8.37%Trim
Mar 1, 2025SellVNDAKevin Patrick MoranSVP, CFO & Treasurer26,941$4.76$327.1M-45.27%+31.40%$128.2K-7.57%Trim
Mar 1, 2025SellVNDAGunther BirznieksSVP, Business Development26,941$4.76$327.1M-45.27%+31.40%$128.2K-6.14%Trim
Mar 1, 2025SellVNDAMihael Hristos PolymeropoulosPresident and CEO105,999$4.75$327.1M-45.27%+31.40%$504.0K-1.86%Trim
Feb 28, 2025BuyVNDAMihael Hristos PolymeropoulosPresident and CEO10,000$4.76$327.1M-45.27%+31.40%$47.6K+0.43%Trim
Feb 27, 2025BuyVNDAMihael Hristos PolymeropoulosPresident and CEO10,000$4.76$327.1M-45.27%+31.40%$47.6K+0.43%Trim
Feb 26, 2025BuyVNDAMihael Hristos PolymeropoulosPresident and CEO10,000$4.76$327.1M-45.27%+31.40%$47.6K+0.21%Trim
Feb 25, 2025BuyVNDAMihael Hristos PolymeropoulosPresident and CEO10,000$4.46$327.1M-45.27%+31.40%$44.6K+0.43%Trim
Feb 21, 2025BuyVNDAKevin Patrick MoranSVP, CFO & Treasurer2,000$4.39$327.1M-45.27%+31.40%$8.8K+0.57%Trim
Jul 29, 2024SellVNDAKevin Patrick MoranSVP, CFO & Treasurer2,251$5.92$327.1M-45.27%+31.40%$13.3K-0.97%Trim
Mar 4, 2024SellVNDAKevin Patrick MoranSVP, CFO & Treasurer14,700$4.31$327.1M-45.27%+31.40%$63.4K-3.03%Trim
Mar 4, 2024SellVNDAJoakim WijkstromSVP, Chief Marketing Officer16,727$4.30$327.1M-45.27%+31.40%$71.9K-5.86%Trim
Mar 4, 2024SellVNDATimothy WilliamsSVP & General Counsel17,088$4.29$327.1M-45.27%+31.40%$73.3K-4.07%Trim
Mar 4, 2024SellVNDAGunther BirznieksSVP, Business Development17,411$4.21$327.1M-45.27%+31.40%$73.4K-2.67%Trim
Mar 4, 2024SellVNDAMihael Hristos PolymeropoulosPresident and CEO55,172$4.19$327.1M-45.27%+31.40%$231.3K-1.44%Trim
Aug 21, 2023SellVNDAJoakim WijkstromSVP, Chief Marketing Officer3,724$5.84$327.1M-45.27%+31.40%$21.7K-3.17%Trim